Case Smoking and cessation in the hospitalized patient Using the 5A s in the hospitalized patient Practical use of drug therapy for cessation
|
|
- Thomasine Carpenter
- 5 years ago
- Views:
Transcription
1 Allan Prochazka, M.D., M.Sc. F.A.C.P. Professor of Medicine University of Colorado School of Medicine Asst. Chief, Research Ambulatory Care Denver VAMC Case Smoking and cessation in the hospitalized patient Using the 5A s in the hospitalized patient Practical use of drug therapy for cessation Co-Investigator on VA Health Services Research Grant Improving the delivery of smoking cessation guidelines in hospitalized veterans
2 56 yo man admitted for pancreatitis PMH: HTN, Type II DM, DJD, ETOH Social: cigarettes per day since age 16, Marlboro, several brief prior quit attempts, last year took a couple varenicline tablets from a friend and said it made cigarettes taste bad, tried nicotine patch 14 mg for a few days in 2006 without much success Day 2, pain is improving, pt is starting to take clear liquids and is complaining to the nurses about the smoking restrictions in your hospital. After lunch he tried to leave the ward with his IVAC to get outside to smoke What to do now? 1. Is it safe to prescribe medications to control withdrawal symptoms in hospitalized patients? Yes No Not sure
3 2. Which is the best choice to control withdrawal symptoms in this patient? Buspirone 5 mg daily Nicotine lozenge 2 mg q 1-2 hr as needed Bupropion 300 mg daily Nicotine patch 21 mg daily Nicotine patch 14 mg daily The patient is ready for discharge, how long should one typically continue antismoking medications? 1-2 weeks 3-4 weeks 4-6 weeks 8-12 weeks 24 weeks
4 CDC, National Health Interview Survey CDC Cessation Fact Sheet, 2010 Smoking in Hospitalized Patients Current rates of smoking among hospitalized medical patients On VA wards, about 30% Cook County, 36% 1 Hospitalized patients often suffer from withdrawal symptoms and may smoke while admitted Survey from Boston 2 1 Katz A, et al. J Hosp Med 2008;3: Rigotti NA, et al, Prev Med 2000;31:
5 Unpublished VA Pilot Data COPD patients admitted for exacerbations 48% received smoking cessation counseling 1 1 Yip NH, et al. COPD 2010;7:85-92 Many smokers are hospitalized for conditions related to their habit Smokers may have low awareness (or denial) about the relationship between their medical conditions and tobacco (e.g. peripheral vascular disease) About 40% in a Boston study indicated they are ready to quit in the next 30 days 1 At Denver Health, 20% indicated they had already taken action to quit 2 and at 20 months f/u, 18% had quit 3 Cardiology pts in Chicago, 15% smoked and 75% said they were ready to quit 4 1 Rigotti NA, et al. Am J Prev Med 1999;17: Vernon JD et al. Prev Med 1999;28: MacKenzie TD, et al. Prev Med 2004;39: Shah LM, et al. J Hosp Med 2010;5:26-32 Acute Coronary Syndrome 420 smokers in Greece 1, 40% quit at one year Of those who attended a cessation program after hospital discharge, 48% quit 136 Smokers in Michigan (23% of those enrolled) 48% quit after discharge and stayed quit for up to 1 year 2 CABG 146 smokers underwent CABG 93% quit at 3 months post surgery 3 Veterans (n=354) 15% quit at 6 months post discharge Those who didn t smoke during the admission, 2.7 X higher odds of being quit at 6 months 4 1 Vogiatzis I, et al. Hellenic J Card 2010;51: Holtrop JS et al. J Hosp Med 2009;4:E3-E9 3. Pietroban RC, Barbisian JN. Rev Bras Circ Cardiovasc 2010;25: Duffy SA, et al. Prev Med 2010;50:
6 Surveys suggest that we generally are treating withdrawal in the hospital and don t focus on enhancing long term cessation NRT (nicotine replacement) twice as likely to be given to a pt experiencing withdrawal than to other smokers 1 Take advantage of the teachable moment and help patients with cessation Recent guidelines based on systematic review of 3000 trials concluded 2 : Physician counseling is effective Quitlines are effective Virtually all smokers can benefit from drug therapy to help with quitting, not just those who are highly dependent So, switch the focus from short term withdrawal control to developing a cessation plan 1 Rigotti NA, et al. Am J Prev Med 1999;17: Treating Tobacco Use and Dependence: 2008 Update, USDHHS, Public Health Service Cochrane Systematic Review of Trials 1 All trials including smokers and recent quitters (< 1 month) Intervention started in the hospital Followup of at least 6 months 29 trials found with 15,000 participants Wide variety of designs and moderate heterogeneity in the results 1 Rigotti NA, et al. Cochrane Database of Systematic Reviews, 2007 Brief Hospital Advice > 15 minutes in Hospital Advice Hospital Advice + Short f/u 6 Month Cessation Outcomes by Intensity of Counseling # Studies # Subjects OR 95% CI Hospital Advice + More than 1 month f/u support Overall
7 Study Intervention Control OR 95% CI Campbell 1991 Campbell /107 21/ /30 3/ Lewis /62 6/ Molyneux 2003 NRT vs Placebo or no NRT 10/91 4/ Vial /42 1/ Overall 52/332 35/ Bupropion vs Placebo Study Intervention Control OR 95% CI Rigotti /124 17/ Brief advice in the hospital is not enough to achieve long term cessation Linking hospital based advice with outpatient followup clearly works, the more the better Addition of nicotine replacement therapy is probably helpful, but not enough data to say definitively. Minimal toxicity Suggestion of benefit from bupropion, but only one study Ask Advise Assess Assist Arrange
8 Ottawa Model 1,2 Implemented the 5A s across all providers in 9 hospitals Trained staff Templates/pathways for each step Continuous abstinence rates at 6 months 29% vs 18% with usual care (p=0.02) 1. Reid RD, et al. Nicotine Tob Res 2010;12: (accessed 9/14/10) Ask all patients 18 and older whether they smoke. Grade A recommendation USPSTF 1 Makes smoking salient for patients and providers Triggers quit attempts by patients and advice/ interventions by providers Electronic medical records can make this easier 2 Training nurses to ask routinely as part of their admission evaluation increased asking and advising from 57% to 86% of admissions 3 Remember that patients may have quit during the prodrome of their illness, they are still smokers until they actively work towards quitting 1 US Preventive Services Task Force. Ann Intern Med 2009;150: Linder JA, et al. An electronic health record based intervention to improve tobacco treatment in primary care. Arch Intern Med 2009;169: Duffy SA, et al. J Gen Intern Med 2010;25 Suppl 1:3-10. Strongest data in general are for physician advice Other clinicians also likely to be effective Systematic review showed that brief advice alone is probably not enough for many hospitalized smokers Ideal to have a consistent approach across providers to reinforce the message Patients will receive advice from multiple sources Best to avoid preaching/nagging, stay friendly and positive about the possibilities for change Remind patient that relapse often occurs with a short time after discharge and we can help prevent that Baxter S, et al. Nicotine Tob Res 2010;(epub 5/14/10)
9 Clear: I think it s important for you to quit smoking now and I can help you. Strong: As your doctor, I need you to know that quitting smoking is the best thing you can do for your health. Your care team and I will help you. Personalized: Smoking robs your body of oxygen and limits your breathing, quitting will greatly improve how far you can walk. Don t try to force cessation on the patient Reinforce that help is available when they are ready Many times these patients will surprise you and either quit on their own or be ready to quit at a future visit to their PCP Identify willingness to quit Are you willing to give quitting a try? You ve been forced to fast from smoking in the hospital, have you thought about quitting for good? If yes, can we start now. Are you having problems with being off cigarettes? If ready now, then consider drug therapy while in the hospital If not ready, then work on motivation and on barriers
10 Identify the barriers Fear of weight gain Worry about urges Too much stress, etc. Now is a great time to quit, you have already gone xx days without smoking Give tailored information about benefits of quitting, risks of smoking, availability of treatment E.g. We can use medication to take the edge off urges after quitting. Identify Tobacco Dependence DSM IV R criteria Withdrawal with cessation Smoking in the face of medical illness Fagerstrom How soon after awakening do you smoke your first cigarette? If < 5 minutes, then highly dependent Behavioral key is to to start in the hospital and link to the outpatient setting Drug Therapy Smokers wanting to quit need both in most cases Dose of each one can be tailored to the patient s needs and availability of help
11 Key element is time with patient and empathic counselor More time, more benefit e.g. NRT or bupropion plus 2 phone calls 23% cessation at 24 months in an outpatient setting Ellerbeck EF, et al. Effect of varying levels of disease management on smoking cessation. Ann Intern Med 2009;150: Practical Recommendations for patients Tell family, friends, coworkers Make the home smoke free when you go home Start acting like a non-smoker Identify barriers to cessation Remove tobacco products from environment Review prior quit attempts, learn from them Anticipate triggers and challenges Encourage others in the home to quit Provide a supportive clinical environment (e.g. We can help you if you are having problems ) Provide options Referral not always available Quitlines are proven to increase success rates in outpatients, available in most states and are free Mottillo S, et al. Behavioural interventions for smoking cessation: a meta-analysis of RCT s. Eur Heart J 2009;30: Lichtenstein E, et al. Amer Psychol 2010;65: Self-help materials All forms of approved drug therapy would be possible in principle for a hospitalized patient, but there are sparse data Select based on potential side effects, time to action, nursing considerations, prior patient experience and preferences FDA Approved Agents for Smoking Cessation Nicotine Replacement (NRT) Bupropion Varenicline
12 Most commonly used therapy in studies of hospitalized patient smoking cessation Need to avoid in patients with ACS Dose Forms Frequent Dosing (i.e. q 1-2 hrs prn) Gum Lozenge Inhaler Nasal Nicotine Daily Dosing Patch Daily dosing easier to administer in a hospitalized patient than ad lib or prn dosing Overall success rate comparable among the products Odds ratios for quitting: Patch 1.66; Gum 1.43; Lozenge 2.00; Inhaler 1.90; Nasal Spray 2.02 Doubles the quit rate (e.g. 5-8% to 10-15%) compared to advice (e.g. 10% to 17%) compared to placebo, overall odds ratio 1.58 (based on 40,000 patients studied, 132 trials) L Stead et al, NRT for Smoking Cessation, Cochrane Review, 2008 Selection based on side effects, patient preference, insurance coverage PDR duration of therapy 8-12 weeks Selected patients need longer therapy or higher doses Schnoll RA et al. Effectiveness of extended duration transdermal nicotine therapy:a randomized trial. Ann Intern Med 2010;152: strengths (21, 14, 7 mg/24hr) Onset of action is within hours, steady state in days Some patients require higher doses (e.g. very heavy smokers), but for typical pack a day smoker 21mg is the starting dose In the hospitalized patient would hold on higher dose therapy until after discharge 4-6 weeks on 21 mg, 2-4 weeks on 14 mg, then 2-4 weeks on 7 mg Costs $25-40 per 14 day supply Side Effects Skin irritation (30%) Skin allergy (1-4%) Poor sleep/nightmares (10%) Arm pain (2-4%)
13 2 forms (2 mg and 4mg), 4 mg best for most smokers Available OTC and in generic forms and in various flavors Absorption is buccal, so park and chew Regular dosing better than ad lib Typical patient will use 5-8 pieces per day Retail cost $35-50 for 108 pieces Side Effects Dental trauma, jaw pain, nausea, upset stomach Duration of Use 8-12 weeks 2-5% have trouble quitting gum Long term use combined with behavioral therapy (up to 5 years) safe and effective, 25% validated quit rate in Lung Health Study Available OTC, 2 mg and 4 mg Allow lozenge to slowly dissolve, no chewing or swallowing of the lozenge need to be careful not to develop too much saliva minutes per lozenge Dose 20 max per day Side effects: hiccups, nausea, stomach upset, palpitations Cost $ for box of 72 lozenges Very rapid absorption of nicotine Useful in the heavily dependent smoker because high levels are achieved in a few minutes Dosing 0.5 mg per spray, one spray in each nostril is one dose (about the amount of nicotine in one cigarette) Typical patient uses 3-6 doses per day Side Effects: mostly irritation, face pain, perhaps more likely to result in difficulty stopping use due to fast absorption Costs $45-50 per 10 ml vial (100 doses)
14 Each cartridge 10 mg nicotine, 4 mg released, 2 mg absorbed Best with continuous puffing (80 deep inhalations over 20 minutes give 2 mg nicotine, about the same as one cigarette) Dosage 6-16 cartridges per day Side Effects: mouth/nose irritation Costs up to $160 per 168 cartridges (about 2-4 weeks supply) Has been tested in many trials (however, not in the hospital setting), so reserve for the patient once stable and home Higher dose patches not better when given as a routine for all smokers, best to titrate by intake/level of dependence Useful for the very heavy smoker Safety in trials and practice has been good Nicotine patch+nicotine gum or lozenge Higher quit rate than either alone Allows for steady level with ad lib gum Cochrane review (6 trials of high dose or combo therapy) odds ratio for quitting 1.21 (95% CI ) compared to monotherapy Primary care trial found that cessation rate with patch/lozenge was 27% at 6 months compared to 18% with patch alone Smith SS, et al. Arch Intern Med 2009;169: Main limitation is the cost of the therapy In the pt who has cut down recently, should generally dose based on their long term use level Ad lib meds with frequent dosing (e.g. gum, lozenge, inhaler, nasal spray) are hard to implement in a hospital environment Nicotine patch is the simplest from a dosing/ nursing perspective When person goes home, can switch to the mode of delivery and dosing regimen that fits best for the patient
15 Works in normal, non-depressed smokers Relatively slow onset of action (7-10 days) SA form is only type approved for cessation Dosage: 150 mg a day for 3 days, then 150 mg bid, but not much difference in effectiveness between 150 and 300 mg /day Only one trial on use in hospitalized patients, trend towards effect but not significant Duration: 3 months, but longer term therapy is safe and effective in outpatients Minimal cardiovascular effects when given alone $70/month for generic long acting bupropion Side Effects Common Shaky,tremor Headache Dry mouth Rare but serious Seizures Avoid in those with epilepsy, active drug use, concomitant psychiatric medications, bulemia, MAOI use Rare, not a large problem Worsened HTN when combined with NRT Allergic reactions (hives, angioedema) Overall odds ratio for cessation 1.94 (95% CI 1.72 to 2.19) based on 19 trials Hughes JR et al, Cochrane Review 2007 Combination Therapy (patch+oral inhaler+bupropion) can work well with quit rates at 26 weeks 35% compared to 19% with patch alone and acceptable side effects Steinberg MB, et al. Triple Combination pharmacotherapy for medically ill smokers. Ann Intern Med 2009;150: Combined with lozenge, 30% 6 month quit rate Smith SS, et al. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med 2009;169: Less weight gain than with patch
16 Very useful Healthy populations (e.g. worksite) Active cardiac disease Harder to use in some patient groups Psychiatric comorbidity Substance Abuse Will work in the hospital setting, but probably won t kick in quickly enough to help the person with severe withdrawal symptoms Bottom Line: very useful agent overall, limited info on use in the hospital, but may be a good choice in the cardiac patient, main issue is caution with regard to seizure risk First designer drug for tobacco dependence 1 A derivative of cytisine, derived from the golden rain tree Hasn t really been a clinical reason to know about central nicotine receptors before this, but interactions with the α4β2 receptor are the main mechanism of action Acts as a partial agonist causing dopamine release, also is an antagonist and blocks the binding of exogenous nicotine 1. Hays JT, Ebbert JO, NEJM 2008;359: Varenicline Cessation Efficacy at 24 Wks 1 1. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006103
17 Copyright restrictions may apply. Treatment-Emergent Adverse Events (Including Those Not Necessarily Related to Study Drug)* Gonzales, D. et al. JAMA 2006;296: smokers, stable CVD (hx MI, Revasc, Angina, PVD, Cerebrovascular) Excluded recent procedure or unstable CAD, uncontrolled HTN, severe CHF, severe COPD, liver, GI, Diabetes (A1c >9), psych or recent psych tx, drug use 1. Rigotti NA, et al. Circulation 2010;121: Tobacco CARs Rigotti, N. A. et al. Circulation 2010;121: Copyright 2010 American Heart Association
18 Varenicline effective compared to placebo with at least a doubling of the quit rate OR 2.33 (95% CI ) Cahill C. Cochrane Review, 2008 Moderately (OR 1.52, 95% CI ) better quit rate than bupropion SA Perhaps better than NRT (OR 1.33 ( ), but few trials Nausea was the most predominant side effect Rate of drug discontinuation was relatively low In approval RCT s 2 cases of psychosis Numerous case reports since approval Worsening of schizophrenia 5 days after starting varenicline in patient who was stable on low dose neuroleptic Mania requiring hospitalization 1 week after starting varenicline in a bipolar patient who was stable on valproate Am J Psych 2007;164: UK 2682 pts in general practice 2 cases of attempted suicide Mood change/depression 1.7% Anxiety 1.2% Kasliwsal, et al. Drug Safety 2009;32: VA PBM July 2009, 149 cases of suicidal behaviors out of approximately 100,000 patients treated VA Bulletin, July 2, 2009
19 Market Share Varenicline Bupropion Varenicline Bupropion# Nicotine Control* 13% 7% 77% n/a Suicides Attempts Ideation Agression Moore TJ, Furburg CD, BMJ 2009;339: # all indications * Amoxicillin July 2009 Watch for changes in behavior, hostility, agitation, depressed mood, suicidal thinking and behavior Stop the meds if above occur and monitor until resolved Rates of suicide and depression are low (less than 1/1000), but warrants caution with both drugs in patients with psychiatric disorders and also means that both should be prescribed only with adequate followup Expensive ($370 for mg tabs, enough for 12 weeks) No data on use in hospital setting, so wouldn t recommend starting it there Best to save for those who have failed first line therapies once they have gone home VA Guidelines Second line agent Avoid in patients with psychiatric disorders unless working collaboratively with mental health provider Monitor after starting therapy on regular basis
20 Link the patient to the Colorado Quitline Make sure that the PCP knows that an active quit attempt has been started If your hospital does post-discharge calls to patients, consider adding smoking status to the questions Smoking remains a problem in hospitalized patients 5 A s approach works Consider expanding the use of drug therapy beyond those who have acute withdrawal Link patient to outpatient resources to support the quit attempt
Effective Treatments for Tobacco Dependence
Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for
More informationSmoking Cessation: Where Are We Now? Nancy Rigotti, MD
Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for
More informationPharmacologic Therapy for Tobacco Use & Dependence
Pharmacologic Therapy for Tobacco Use & Dependence Thomas Gauvin, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 Learning Objectives Understand the 7 first line medications
More information5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.
0 11 Key Messages 1. Ask and document smoking status for all patients. 2. Provide brief advice on quit smoking at every visit to all smokers. 3. Use individual, group and telephone counselling approaches,
More informationMedication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019
Medication Management to Aid in Smoking Cessation Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 1 Learning Objectives: Review the prevalence of tobacco use. Describe tools
More informationHelping People Quit Tobacco
Helping People Quit Tobacco Peter Selby MBBS, CCFP, MHSc, ASAM Associate Professor, University of Toronto Clinical Director, Addictions Program, CAMH Principal Investigator, OTRU Disclosures! Grants/research
More informationPharmacotherapy for Tobacco Dependence Treatment
Pharmacotherapy for Tobacco Dependence Treatment Nancy Rigotti, MD Professor of Medicine, Harvard Medical School Director, Tobacco Research and Treatment Center, Massachusetts General Hospital nrigotti@partners.org
More informationSmoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service
Smoke-free Hospitals Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Today s Subjects 5A s and Clinician Training and Use with the Hospitalized Patient NRT use in
More informationMy Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon.
My Mask KL I keep it all inside Because I d rather The pain destroy me Than everyone else. Anon. 43 K. N. Roy Chengappa, M.D., FRCPC Professor of Psychiatry, University of Pittsburgh School of Medicine,
More informationSMOKING CESSATION WORKSHOP. Dr Mark Palayew December
SMOKING CESSATION WORKSHOP Dr Mark Palayew December 5 2016 Conflicts of Interest None Case 1 Mr. T is a 55 year old smoker 2 packs/day He has been smoking continuously since age 16 When he wakes up at
More informationSMOKING CESSATION IS HARD
POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping
More informationSMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami.
SMOKING CESSATION 08 Recommendations 5As Approach to Intervention Stages of Change Assisting the Smoker Pharmacotherapy Contributor Dr. Saifuz Sulami Advisor Dr. Audrey Tan 79 nhg_guideline_14102010_1112.indd
More informationBreaking the Chains of Nicotine Dependence - A Breakthrough Approach
Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Dr Rob Young Senior Lecturer & Consultant Physician Auckland Hospital, New Zealand Smoking Cessation in 2001 Smoking contributes to
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationSmoking Cessation Interventions In Hospital Settings: Implementing the Evidence
Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Nancy Rigotti, MD Tobacco Research & Treatment Center, General Medicine Division, Massachusetts General Hospital, Harvard
More informationIMPORTANT POINTS ABOUT MEDICATIONS
IMPORTANT POINTS ABOUT MEDICATIONS The U.S. Food & Drug Administration (FDA) advises that there are significant health benefits to quitting smoking. The health benefits of quitting smoking include a reduction
More informationTreating Tobacco Use:
Treating Tobacco Use: Optimizing for the Best Outcomes Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org Primary
More informationPharmacotherapy for Treating Tobacco Dependence
Pharmacotherapy for Treating Tobacco Dependence Sheila K. Stevens, MSW Education Coordinator Nicotine Dependence Center 2013 MFMER slide-1 Rationale for Pharmacological Therapy Success rate doubles Manage
More informationHIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA
HIV and Aging Making Tobacco Cessation a Priority in HIV/AIDS Services June 27, 2008 Amanda Brown, MPH Ruth Tripp, MPH, RN Objectives To explore existing knowledge of the HIV and smoking connection. To
More informationOutpatient Tobacco Addiction Treatment Pathway Additional Notes
Outpatient Tobacco Addiction Treatment Pathway Additional Notes First Line: Varenicline (provide in conjunction with counselling/support, but if such support is refused or is not available, this should
More informationTOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS
Learning Objectives TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of
More informationVarenicline Update. Serena Tonstad, MD, PhD Dept of Preventive Cardiology Ullevål University Hospital Oslo, Norway
Varenicline Update Serena Tonstad, MD, PhD Dept of Preventive Cardiology Ullevål University Hospital Oslo, orway October 23, 2015 Disclosures related to smoking cessation: Pfizer, Mceil, ovartis Binding
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationNicotine Replacement Therapy, Zyban and Champix. Name of presentation
Nicotine Replacement Therapy, Zyban and Champix Nicotine Replacement Therapy (NRT) - Rationale for use Nicotine is highly addictive and causes unpleasant withdrawal symptoms which often undermine a quit
More informationVarenicline and Other Pharmacotherapies for Tobacco Dependence
Varenicline and Other Pharmacotherapies for Tobacco Dependence J. Taylor Hays, M.D. Associate Director Nicotine Dependence Center Mayo Clinic 2012 MFMER slide-1 Learning Objectives Understand the mechanism
More informationPharmacologic Therapy for Tobacco Use & Dependence Nicotine Replacement Therapy (NRT) and Bupropion
Pharmacologic Therapy for Tobacco Use & Dependence Nicotine Replacement Therapy (NRT) and Bupropion Jennifer Bluem Moran, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1
More informationPharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1
Pharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1 Compiled by: TOP, in collaboration with Dr. Charl Els and Mr. Ron Pohar: TRaC II (Alberta Medical Association/Primary
More informationTOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS
TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of Pharmacy Learning
More informationChantix Label Update 2018
Chantix Label Update 2018 Chantix (varenicline) Prescribing Information Chantix Prescribing Info URL and Disclaimer Please refer to the full Prescribing Information on important treatment considerations
More informationAddressing Tobacco Use in Iowa
Addressing Tobacco Use in Iowa A BRIEF TOBACCO INTERVENTION FOR HEALTHCARE PROVIDERS Lorene Mein Beth Turner Alyssa Reichelt DNP, ARNP, FNP-BC MA, CHES MA Mercy Clinics American Lung Association American
More informationClearing the Air: What You Need to Know and Do to Prepare to Quit Smoking
Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course Creating Success! THINK ABOUT Process of Changing an Addiction Your Pros and Cons of Smoking and Quitting
More informationTobacco Cessation For Providers. Betty Murphy Health Promotion Program Naval Hospital Rota
Tobacco Cessation For Providers Betty Murphy Health Promotion Program Naval Hospital Rota Tobacco Statistics Strategies for Implementation Stages of Change Pharmacotherapy Tobacco Use Statistics 70% of
More informationUPDATE TREATMENT OF TOBACCO USE DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences UPDATE TREATMENT OF TOBACCO USE DISORDERS MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Remind everyone
More informationAn Evolving Perspective on Smoking Cessation Therapies
An Evolving Perspective on Smoking Cessation Therapies Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe,
More informationSmoking cessation therapy
Appendix 1 Smoking cessation therapy Q. Can a dentist prescribe medications for smoking cessation? A. Yes. Dentists are allowed and are encouraged to help patients with smoking cessation by counseling
More information1. Describe the benefits of smoking cessation. 2. List the withdrawal symptoms of quitting smoking. Cessation
Time to Butt Out Adil Virani, BSc (Pharm), Pharm D, FCSHP Objectives After this presentation, participants should be able to: 1. Describe the benefits of smoking cessation 2. List the withdrawal symptoms
More informationTobacco Use Dependence and Approaches to Treatment
University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Tobacco Use Dependence and Approaches to Treatment Audrey Darville University of Kentucky, audrey.darville@uky.edu Chizimuzo
More informationHow to help your patient quit smoking. Christopher M. Johnson MD, PhD
How to help your patient quit smoking Christopher M. Johnson MD, PhD Outline Smoking and its effects on IBD CD UC Clinical interventions Pharmacotherapy Resources Outline Smoking and its effects on IBD
More informationMonth/Year of Review: March 2014 Date of Last Review: April 2012
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Copyright 2012 Oregon State University. All Rights
More informationUpdate on Medications for Tobacco Cessation
Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction
More informationReady to give up. Booklet 3
Ready to give up Booklet 3 This booklet is written for people who have decided that they want to stop smoking. You can use this booklet on its own or go through it with the person who gave it to you. You
More informationTobacco Cessation, E- Cigarettes and Hookahs
Objectives Tobacco Cessation, E- Cigarettes and Hookahs Discuss evidence-based tobacco cessation interventions including pharmacologic options. Review e-cigarette and hookah facts and safety considerations.
More information21 INSTRUCTOR GUIDELINES
STAGE: Ready to Quit Ms. Crosby is a 32-year-old woman who recently began attending a worksite group program for smoking cessation. Her group has set a quit date for one week from today, and she would
More informationTobacco & Nicotine: Addiction and Treatment
Tobacco & Nicotine: Addiction and Treatment Tim McAfee, MD, MPH Chief Medical Officer - Free & Clear 206-876-2551 - tim.mcafee@freeclear.com Affiliate Assistant Professor, University of Washington, School
More informationTobacco use assessment, brief counseling,, and quit line referral
Tobacco use assessment, brief counseling,, and quit line referral What is the evidence for tobacco cessation counseling? Tobacco use is the leading cause of preventable death in the US 1 Counseling and
More informationClearing the Air: What You Need to Know and Do to Prepare to Quit Smoking. Getting Ready to Quit Course
Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course Sponsored by: American Lung Association of Maryland, Baltimore County Health Department & MDQuit Can
More information9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives
The Smoking Gun: for Smoking Cessation in Patients with Mental Health Disorders BRENDON HOGAN, PHARMD PGY2 PSYCHIATRIC PHARMACY RESIDENT CTVHCS, TEMPLE, TX 09/23/2016 I would feel comfortable dispensing/prescribing
More informationTobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing GOAL To build the capacity of prescribing clinicians in behavioral health settings to integrate best practices for prescribing
More informationYou Can Make a Difference!
You Can Make a Difference! How to help your clients become tobacco free What Does Smoking Cost Us? One study estimates that cost savings of between $1,142 and $1,358 per pregnancy can be achieved for each
More informationSmoking Cessation for Persons with Serious Mental Illness
Smoking Cessation for Persons with Serious Mental Illness MDQuit Best Practices Conference January 22, 2009 Faith Dickerson, Ph.D., M.P.H. Sheppard Pratt Health System Lisa Dixon, M.D., M.P.H. Melanie
More informationPHARMACOTHERAPY OF SMOKING CESSATION
PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure
More informationSmoking Cessation. May
Smoking Cessation Dear Colleague: The impact of smoking, especially for those with chronic illness, is known and staggering. Currently, there are 46.6 million smokers in the U.S., where tobacco use is
More informationCessation Medicine Reference Guide Table of Contents
Cessation Medicine Reference Guide Table of Contents 1. Patch 2. Nicotine Gum 3. Nicotine Lozenge 4. Inhaler 5. Nasal Spray 6. Bupropion SR (Zyban) 7. Chantix (Varenicline) Patch Typical course of therapy
More informationTREATMENT INTERVENTIONS
SMOKING CESSATION TREATMENT INTERVENTIONS Smoking and Health Tobacco is the single most preventable cause of death in the world today. kills more than five million people By 2030, the death toll will exceed
More information3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine
How can there be a warning regarding concomitant use of varenicline with nicotine replacement therapy yet patients can be on varenicline and smoke concurrently? April 20, 2017 The United States (US) Preventive
More information4/2/2015. Inpatient Smoking Cessation. Smoking Cessation Documentation Patient's Stage of Behavior Change
Implementing Updates Barbara Darsow COTA/BA, CES TEAM Project: Promoting in Hospital Patients 1996 Smoke Free 2000 Coalition Completed Training Smoking cessation counselor at Mayo Clinic Tobacco research
More informationA Guide to Help You Reduce and Stop Using Tobacco
Let s Talk Tobacco A Guide to Help You Reduce and Stop Using Tobacco Congratulations for taking this first step towards a healthier you! 1-866-710-QUIT (7848) albertaquits.ca It can be hard to stop using
More informationFundamentals of Brief Cessation Counseling Approaches
Fundamentals of Brief Cessation Counseling Approaches Jamie S. Ostroff Ph.D. Director, Smoking Cessation Program Memorial Sloan Kettering Cancer Center Co-Project Leader Queens Quits! Cessation Center
More informationSmoking Cessation Strategies: What Works?
Smoking Cessation Strategies: What Works? Andrew M. Busch, Ph.D. Centers For Behavioral and Preventive Medicine The Miriam Hospital Department of Psychiatry and Human Behavior Alpert Medical School of
More informationHealth Professional Manual
Health Professional Manual Session: Smoking Cessation Smoking and COPD Strategies for quitting smoking Adapted from the Living Well with COPD program (2nd edition), Montreal Chest Institute, Canada SESSION
More informationVarenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?
Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks? Sonal Singh M.D., M.P.H, Johns Hopkins University Presented by: Sonal Singh, MD MPH September 19, 2012 1 CONFLICTS
More informationQuestions to ask your healthcare professional
Prepare to quit Get ready! Talk to your healthcare professional about how to quit Set a date for quitting. Choose a date that is within the next 2 weeks and make a strong commitment to quit on that day
More informationDrug Use Evaluation: Smoking Cessation
Drug Use Research & Management Program Oregon State University, 3303 SW Bond Av CH12C, Portland, Oregon 97239-4501 Phone 503-947-5220 Fax 503-494-1082 Drug Use Evaluation: Smoking Cessation Tobacco cessation
More informationTobacco treatment for people with serious mental illness (SMI)
Tobacco treatment for people with serious mental illness (SMI) An opportunity to close the mortality gap Massachusetts Mental Health Center 1 National Resource Center for Academic Detailing A compelling
More informationQuitting is all about finding what works for you.
Quitting is all about finding what works for you. Your guide to finding the right support 02 Smokefree Your way Well done you I can do it! Smokefree provides advice, support and encouragement to help people
More informationSmoking Cessation Strategies in 2017
Smoking Cessation Strategies in 2017 Robert Schilz DO, PhD, FCCP Division of Pulmonary, Critical Care and Sleep Medicine Director of Lug Transplantation University Hospitals of Cleveland Case Western University
More informationManagement of Perinatal Tobacco Use
Management of Perinatal Tobacco Use David Stamilio, MD, MSCE Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, UNC School of Medicine Funding for this project is provided in
More informationNYSMPEP Smoking Cessation Guidance: Key Message 3
NYSMPEP Smoking Cessation Guidance: Key Message 3 Key Message 3: All smokers trying to quit should be offered medication (except when contraindicated or for specific populations). The Agency for Healthcare
More informationSMART STEPS towards a tobacco-free life
SMART STEPS towards a tobacco-free life Ready to Quit Smoking? You decide when. We ll show you how. Smart steps... Ready to Put Tobacco Behind You? Congratulations on deciding to quit! Quitting tobacco
More information4 INSTRUCTOR GUIDELINES
STAGE: Recent Quitter You are a clinician working on the vascular surgery service and are about to discharge Mr. McCray, a 58-year-old patient who recently underwent a femoral artery bypass graft for peripheral
More informationMEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Smoking Cessation Products LAST REVIEW 5/8/2018 THERAPEUTIC CLASS: Psychiatric Disorders REVIEW HISTORY 5/17, 5/16, 5/15,
More informationTobacco Cessation The Role of the Dentist/Oral Medicinist
Tobacco Cessation The Role of the Dentist/Oral Medicinist Jennifer Frustino, DDS PhD Oral Oncology & Maxillofacial Prosthetics Erie County Medical Center Buffalo, NY Statement of Disclosure I have no actual
More informationSmoking Cessation Counseling Strategies
Smoking Cessation Counseling Strategies Click to edit Master subtitle style Renato Galindo RRT-CPFT, AE-C, CTTS Objectives: Discuss factors associated with tobacco addiction Discuss tobacco cessation strategies
More informationAl Heuer, PhD, RRT, RPFT Professor & Program Dir. Rutgers School of Health Related Professions
Al Heuer, PhD, RRT, RPFT Professor & Program Dir. Rutgers School of Health Related Professions Learning Objectives Review the Epidemiology and statistics regarding tobacco dependence Identify new tobacco
More informationThere are many benefits to quitting for people with cancer even if the cancer diagnosis is not tobacco-related INCREASED
Stopping tobacco use reduces your risk for disease and early death. There are health benefits at any age. YOU ARE NEVER TOO OLD TO QUIT. Health benefits begin immediately. INCREASED blood oxygen levels
More informationWhat am I Smoking/ Vaping?
What am I Smoking/ Vaping? What s in a cigarette? What s in an e cigarette? Page Image source: http://www.huffingtonpost.com/0//0/effects of quitting smoking_n_.html Page Support for Changing Your Tobacco
More informationPharmacological Treatments for Tobacco Users with Behavioral Health Conditions
Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures
More informationHeather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health
Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health Disclosure Heather Dacus has no real or perceived vested interests that
More informationBrief Intervention for Smoking Cessation. National Training Programme
Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about
More informationTREATMENT OF NICOTINE DEPENDENCE
TREATMENT OF NICOTINE DEPENDENCE Introduction Most commonly used substance the world over. Largest cause of preventable death worldwide. Leading causes of smoking related death Cardiovascular diseases
More informationTreatment of Tobacco Dependence
Treatment of Tobacco Dependence Shamim Nejad MD Swedish Cancer Institute Swedish Medical Center Shamim.Nejad@swedish.org Case: Nancy D. 55 year old woman with right breast cancer, s/p chemoradiation and
More informationExamples of what to say when intervening with smoking clients. Do you smoke cigarettes or tobacco at all, or have you ever smoked regularly?
Manual of Smoking Cessation Andy McEwen, Peter Hajek, Hayden McRobbie & Robert West 2006 by McEwen, Hajek, McRobbie and West Appendix 5 Examples of what to say when intervening with smoking clients Below
More informationSmoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation
Smoking Cessation MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Objectives Tobacco use at population level Tobacco use and control around the world What works for managing tobacco use Common myths
More informationNicotine Replacement Therapy (NRT).
Nicotine Replacement Therapy (NRT). Information for smokers 1 What is NRT? The aim of Nicotine Replacement Therapy (NRT) is to reduce the withdrawal symptoms associated with nicotine addiction by replacing
More informationBest practice for brief tobacco cessation interventions. Hayden McRobbie The Dragon Institute for Innovation
Best practice for brief tobacco cessation interventions Hayden McRobbie The Dragon Institute for Innovation Disclosures I am Professor of Public Health Interventions at Queen Mary University of London
More information8/9/18. Objectives. Smoking. Disclosure Statement. The presenters have no real or potential conflicts of interest related to the presentation topic.
Disclosure Statement Multifaceted Smoking Cessation Strategies for Nurse Practitioners The presenters have no real or potential conflicts of interest related to the presentation topic. Dr. Susan Chaney,
More informationWanting to Get Pregnant
Continuing Medical Education COPD Case Presentation LEARNING OBJECTIVES Those completing this activity will receive information that should allow them to Assist a patient in developing a quit plan; Advise
More informationStriving for Success: Smoking Cessation Strategies among people with Mental Illness
Striving for Success: Smoking Cessation Strategies among people with Mental Illness Carlo C. DiClemente, Ph.D. Director of Professor, University of Maryland, Baltimore County October 15, 2011 NAMI Workshop
More informationTobacco Cessation: Priority for Health Providers. Acknowledgements. Tobacco Cessation: Secondhand Smoke. Smoke-Free Environment & CA
Acknowledgements Smoking Cessation Leadership Center http://smokingcessationleadership.ucsf.edu/ Rx for Change http://rxforchange.ucsf.edu/ Tobacco Use and Dependence: 2008 Update http://www.surgeongeneral.gov/tobacco
More informationFor more information about quitting smoking, contact:
For more information about quitting smoking, contact: UAMS Patient Education Department (501) 686-8084 www.uamshealth.com/patienteducation SOS Quitline 1-800-QUIT-NOW (1-800-784-8669) 4301 West Markham
More informationFormulary and Prescribing Guidelines
Formulary and Prescribing Guidelines SECTION 17: NICOTINE REPLACEMENT THERAPY 17.1 Introduction These guidelines should be used in conjunction with SEPT No Smoking Policy (HRP20) and for service users
More informationTime to Butt Out. Adil Virani, BSc (Pharm), Pharm D, FCSHP
Time to Butt Out Adil Virani, BSc (Pharm), Pharm D, FCSHP Objectives After this presentation, participants should be able to: 1. Describe the benefits of smoking cessation 2. List the withdrawal symptoms
More informationSmoking Cessation Self-Management Plan and Care Plan
Smoking Cessation Self-Management Plan and Care Plan I understand the following items will be beneficial to the treatment of my tobacco abuse, have discussed this with my provider and I agree to implement
More informationOver the Road Truck Driver Who Smokes
Continuing Medical Education Case Presentation 1 CME Credit Physicians Physician Assistants Nurse Practitioners Over the Road Truck Driver Who Smokes RELEASE & REVIEW DATE This activity was last reviewed
More informationThe Quit Clinic As an Anti-smoking Advocacy Tool
The Quit Clinic As an Anti-smoking Advocacy Tool Associate Professor Chanchai Sittipunt MD Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Faculty of Medicine Chulalongkorn
More informationThinking about giving up. Booklet 2
Thinking about giving up Booklet 2 This booklet is written for people who are trying to make up their mind about giving up smoking. A lot of people who smoke have done so for a long time, and like smoking.
More informationSmoking Cessation Strategies for the 21st Century
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/smoking-cessation-strategies-for-the-21stcentury/3862/
More informationSmoking Cessation: Treating Tobacco Dependence
Smoking Cessation: Treating Tobacco Dependence Pat Folan, RN Center for Tobacco Control Pulmonary Medicine NS-LIJ Health System NYS DOH Tobacco Control Program Treating Tobacco Dependence Center for Tobacco
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SMOKING CESSATION Introduction NICE recommends that Nicotine Replacement Therapy (NRT), bupropion [Zyban ] and
More informationPatient Group Direction for the Supply of Varenicline (Champix ) by Authorised Community Pharmacists
Patient Group Direction for the Supply of Varenicline (Champix ) This Patient Group Direction (PGD) is a specific written instruction for the supply of varenicline to groups of patients who may not be
More information